Ebner Jennifer, Aşçı Arslan Ayşe, Fedorova Maria, Hoffmann Ralf, Küçükçetin Ahmet, Pischetsrieder Monika
Food Chemistry Unit, Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Schuhstr. 19, 91052 Erlangen, Germany.
Food Engineering Department, Faculty of Engineering, Akdeniz Üniversitesi, Dumlupinar Boulevard, 07059 Antalya, Turkey.
J Proteomics. 2015 Mar 18;117:41-57. doi: 10.1016/j.jprot.2015.01.005. Epub 2015 Jan 19.
Kefir has a long tradition in human nutrition due to its presupposed health promoting effects. To investigate the potential contribution of bioactive peptides to the physiological effects of kefir, comprehensive analysis of the peptide profile was performed by nano-ESI-LTQ-Orbitrap MS coupled to nano-ultrahigh-performance liquid chromatography. Thus, 257 peptides were identified, mainly released from β-casein, followed by αS1-, κ-, and αS2-casein. Most (236) peptides were uniquely detected in kefir, but not in raw milk indicating that the fermentation step does not only increase the proteolytic activity 1.7- to 2.4-fold compared to unfermented milk, but also alters the composition of the peptide fraction. The influence of the microflora was determined by analyzing kefir produced from traditional kefir grains or commercial starter culture. Kefir from starter culture featured 230 peptide sequences and showed a significantly, 1.4-fold higher proteolytic activity than kefir from kefir grains with 127 peptides. A match of 97 peptides in both varieties indicates the presence of a typical kefir peptide profile that is not influenced by the individual composition of the microflora. Sixteen of the newly identified peptides were previously described as bioactive, including angiotensin-converting enzyme (ACE)-inhibitory, antimicrobial, immunomodulating, opioid, mineral binding, antioxidant, and antithrombotic effects.
The present study describes a comprehensive peptide profile of kefir comprising 257 sequences. The peptide list was used to identify 16 bioactive peptides with ACE-inhibitory, antioxidant, antithrombotic, mineral binding, antimicrobial, immunomodulating and opioid activity in kefir. Furthermore, it was shown that a majority of the kefir peptides were not endogenously present in the raw material milk, but were released from milk caseins by proteases of the microbiota and are therefore specific for the product. Consequently, the proteolytic activity and the composition of the peptide profile can be controlled by the applied microflora (grains or starter culture). On the other hand, a considerable portion of the peptide profile was identified to be typical for kefir in general and independent from production parameters. In summary, the generated kefir peptide profile helped to reveal its origin and to identify bioactive peptides in kefir, which may advance the understanding of health benefits of this food product. The results further indicate that subsets of the kefir peptide list can be used as markers to control food authenticity, for example, to distinguish different types of kefir.
开菲尔因其假定的促进健康作用,在人类营养领域有着悠久的传统。为了研究生物活性肽对开菲尔生理效应的潜在贡献,通过与纳升超高效液相色谱联用的纳升电喷雾电离线性离子阱-轨道阱质谱对肽谱进行了全面分析。由此,鉴定出257种肽,主要来自β-酪蛋白,其次是αS1-、κ-和αS2-酪蛋白。大多数(236种)肽仅在开菲尔中检测到,而在原料奶中未检测到,这表明发酵步骤不仅使蛋白水解活性比未发酵牛奶提高了1.7至2.4倍,还改变了肽组分的组成。通过分析由传统开菲尔粒或商业发酵剂培养物生产的开菲尔来确定微生物群落的影响。来自发酵剂培养物的开菲尔具有230个肽序列,其蛋白水解活性比含有127个肽的开菲尔粒生产的开菲尔显著高1.4倍。两个品种中97种肽相匹配,表明存在不受微生物群落个体组成影响的典型开菲尔肽谱。新鉴定的肽中有16种先前被描述具有生物活性,包括血管紧张素转换酶(ACE)抑制、抗菌、免疫调节、阿片样、矿物质结合、抗氧化和抗血栓形成作用。
本研究描述了包含257个序列的开菲尔全面肽谱。该肽列表用于鉴定开菲尔中具有ACE抑制、抗氧化、抗血栓形成、矿物质结合、抗菌、免疫调节和阿片样活性的16种生物活性肽。此外,研究表明,开菲尔中的大多数肽并非原料奶中内源性存在,而是由微生物群的蛋白酶从牛奶酪蛋白中释放出来的,因此是该产品特有的。因此,蛋白水解活性和肽谱组成可通过应用的微生物群落(开菲尔粒或发酵剂培养物)来控制。另一方面,相当一部分肽谱被确定为一般开菲尔所特有,且与生产参数无关。总之,生成的开菲尔肽谱有助于揭示其来源并鉴定开菲尔中的生物活性肽,这可能会增进对这种食品健康益处的理解。结果还表明,开菲尔肽列表的子集可作为控制食品真实性的标志物,例如区分不同类型的开菲尔。